Preface for special issue on smart nanomedicines for overcoming biological barriers and improving delivery efficiency Authors: Xin Li, Yong Hu, Xiangyang Shi, Andrij Pich Published: 2025 In 2023, Nobel Prize in Physiology/Medicine awarded the mRNA vaccine technology. The synthetic vaccine prepared by encapsulating the modified mRNA within cationic lipid nanocarriers significantly reduces the risk of death from coronavirus disease 2019 (COVID-19). In 2024, Kavli Prize recognizes the pioneering work of integrating engineered nanocarriers with biological functions for biomedical applications. The development of nanomedicine has changed the ways we approach the fundamental understanding, diagnosis, treatment, and prevention of diseases. These successful cases brought great excitement to the field of nanomedicine; however, many challenges still remain. In particular, it is critical to optimize nanocarriers to improve delivery efficiency and selectivity as well as reduce toxic side effects. Currently, various administration ways were adopted, such as oral administration, intravenous injection, arterial intervention, and percutaneous route. When designing the nanocarriers for precise delivery, a key goal is to overcome patient heterogeneity and multiple in vivo barriers. In recent years, some charge reversal and shape transformable nanocarriers, biomimetic and living cell-based systems were developed to simultaneously overcome biological barriers for safe and highly efficient theranostics of various diseases. In this special issue, we are pleased to present seven comprehensive review articles on the enhanced delivery and theranostics of smart nanomedicines. Jiao et al. review the methods of 3D printing used to mimic cartilage structures, the selection of cells and biological factors, and the development of bioinks and advances in scaffold structures, with an emphasis on how 3D printing structure provides bioactive cargos in each stage to enhance the effect. Furthermore, the clinical applications of future development of simulated cartilage printing are introduced, which are expected to provide new insights into this field and guide other researchers who are engaged in cartilage repair. Guo et al. review the preparation and response mechanism of tumor microenvironment-responsive hyperbranched polymers, summarize the latest advances in controlled drug delivery, and analyze the challenges and future research directions for such nanomaterials in clinical applications. Steć et al. review the available literature on the novel concept for extracellular vesicles characterization and discuss the utility of capillary electrophoresis in the quality control of extracellular vesicle-based medicines. Xiang et al. provide an overview of the structural composition and immune mechanisms of outer membrane vesicles (OMVs), detail various OMVs modification strategies, and review the progress in using OMVs for tumor treatment and their anti-tumor mechanisms. The challenges faced in translating OMV-based anti-tumor therapies into clinical practice are discussed. Maisto et al. provide the evidence on natural products with the ability to restore synaptic plasticity alterations in Alzheimer's disease, and the possible application using safe and non-invasive strategies focusing on nanovesicular systems for nose to brain delivery. Wei et al. explore advancements in lysosomal escape mechanisms, essential for enhancing nano-therapeutic efficacy. They delve into novel materials and strategies developed to bypass the lysosomal barrier, including pH-sensitive linkers, fusogenic lipids, and nanoparticles engineered for endosomal disruption. These innovations not only promise to improve therapeutic outcomes but also minimize side effects, marking a significant step forward in the treatment of ovarian, cervical, and uterine cancers. Xiao et al. explore the recent advances and applications of intelligent nanomedicine for the diagnosis and treatment of urinary tumors. The principles of nanomedicine design pertaining to drug encapsulation, targeting and controlled release are discussed, with emphasis on the strategies for overcoming renal clearance and tumor heterogeneity. Moreover, we also feature nine research articles/communications that present the development of novel smart nanocarriers for targeted drug delivery and disease theranostics. Zhang et al. develop a novel lentinan-functionalized poly(b-amino ester)-guanidine-phenylboronic acid nanodiamond system as an adjuvant to induce cGAS-STING pathway-mediated macrophage activation and immune enhancement. Li et al. design a platelet membrane biomimetic nanomedicine that can target and aggregate to the tumor site due to the tumor-targeting ability of platelet membranes. This nanomedicine combines dual depletion of GSH, starvation therapy, and radiotherapy to promote immunogenic cell death and simulate the systemic immune response. Tchatchiashvilli et al. develop poly(ethylene glycol)-block-poly(D,L-lactic-co-glycolic acid) (PEG-PLGA) nanoparticles for targeted antibiotic delivery in bacterial cells, which emphasizes the potential of PEG-PLGA-based formulations for advanced drug delivery strategies. Guo et al. prepare b-glucan-modified nanoparticles with different sizes and surface properties as vaccine carriers, which displays different lymphatic targeting efficiencies and adjuvant effects and offers a novel approach for the enhanced delivery of therapeutic agents to lymph-mediated diseases. Huang et al. study the formulation, characterization, and evaluation of curcumin-loaded ginger-derived nanovesicles for anti-colitis activity by oral administration. The nanovesicles can be used to improve the colon delivery and therapeutic potential. Miao et al. design wheel-shaped polyoxometalates as nanozymes for autophagy-augmented and phototherapy-involved cancer nanotherapy. Ábrahám et al. study the impact of non-ionic surfactant dressing in lipopeptide bioactivity to increase the applicability of lipopeptides as drugs. The internalization rate of peptide-based poloxamer micelle by antigen-presenting model cells exceeds that of the unformulated peptide, indicating that poloxamers as promising tools can be used for the optimization of their selectivity. Hu et al. investigate multi-target effects of Sporoderm-broken spores of Ganoderma Iucidum on improving high-fat diet-induced diabetic nephropathy by transcriptomics, metabolomics, and network pharmacology. Ding et al. demonstrate a nanogel complex as a multilevel reactive oxygen species (ROS)-producing system by integrating chloroperoxidase into gold nanorod-based nanogels for cascade-amplifying photothermal-enzymatic synergistic tumor therapy. Overall, this special issue is a collection of the latest research focusing on smart nanomedicines for overcoming multiple biological barriers in vivo, improving drug delivery processes, and optimizing theranostic efficacy of different diseases. We thank all authors for their contributions, and hope readers will be inspired by these high-quality articles to further promote the development of novel nanomedicines for healthcare applications. Guest Editors Dr. Xin Li DWI-Leibniz-Institute for Interactive Materials, Aachen, 52056, GermanyEmail: xli@dwi.rwth-aachen.de. Dr. Xin Li focuses on the design of smart and bioactive nano-/microgels using sustainable strategies and the exploration of their applications in biocatalysis and biomedicine. Prof. Yong Hu Department of Polymeric Materials, School of Materials Science and Engineering, Tongji University, Shanghai, 201804, ChinaEmail: yonghu@tongji.edu.cn. The research interests of Prof. Dr. Yong Hu and his lab include the innovation of DNA nano-/microstructures for advanced biological applications. Prof. Xiangyang Shi College of Biological Science and Medical Engineering, Donghua University, Shanghai, 201620, ChinaE-mail: xshi@dhu.edu.cn. Prof. Xiangyang Shi's current research interests are focused on the development of organic/inorganic hybrid nanoplatforms (in particular dendrimer-based nanomedicines) and microfluidic platforms for sensing, imaging, and theranostic applications, in the domains of precision imaging and therapy of cancer and inflammatory diseases. Prof. Andrij Pich DWI-Leibniz-Institute for Interactive Materials, RWTH Aachen University, Aachen, 52074, GermanyEmail: pich@dwi.rwth-aachen.de. The research interests of Prof. Andrij Pich and his lab include synthesis of functional polymers and polymer colloids for development of adaptive multicomponent catalysts, transformative carriers for drug delivery and sustainable plant protection systems. Footnotes Peer review under responsibility of Xi'an Jiaotong University.